Industry Complains to EU Over French Law Pushing Cheap Eye DrugIndustry Complains to EU Over French Law Pushing Cheap Eye Drug

Europe's pharmaceuticals industry said on Tuesday it had filed a complaint with the European Commission against a French law promoting the use of Roche's cancer drug Avastin as a cheap treatment for wet age-related macular degeneration (AMD). Reuters Health Information
Source: Medscape Ophthalmology Headlines - Category: Opthalmology Tags: Ophthalmology News Source Type: news